Table 2.
Distribution of allele lengths for the IGF1 STR in the healthy controls, breast cancer cohorts and endometrial cancer cohorts.
CA<19 | CA=19 | CA>19 | n | |
---|---|---|---|---|
Healthy controls | 58 (13.2%) | 299 (67.9%) | 83 (18.9%) | 440 |
Breast cancer cohorts | 67 (15.2%) | 299 (67.6%) | 76 (17.2%) | 442 |
Endometrial cancer cohorts | 61 (15.6%) | 284 (72.8%) | 45 (11.5%) | 390 |
The actual number of allele lengths observed is shown with the percentage of total number of alleles enclosed by parentheses.